Open AccessJournal Article
Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.
Reads0
Chats0
TLDR
Novel ATP competitive cdk inhibitors are being developed with promising results with evidence of antitumor activity and plasma concentrations sufficient to inhibit cdk-related functions.Abstract:
With the understanding of the role of cdks in cell cycle regulation and the discovery that approx. 90% of all neoplasias are the result of 'cdk hyperactivation' leading to the abrogation of the Rb pathway, novel ATP competitive cdk inhibitors are being developed. The first two tested in clinical trials, flavopiridol and UCN-01, showed promising results with evidence of antitumor activity and plasma concentrations sufficient to inhibit cdk-related functions. Best schedule to be administered, combination with standard chemotherapeutic agents and demonstration of cdk modulation from tumor samples from patients in these trials are important issues that need to be answered in order to obtain the best possible results with these agents.read more
Citations
More filters
Journal Article
Apoptosis: Target of cancer therapy
TL;DR: This review discusses in detail approaches to induce tumor cell apoptosis, their mechanism of action, stage of development, and possible drawbacks, and the perspectives for potential clinical use of apoptosis-triggering approaches in cancer therapy in the future are assessed.
Journal ArticleDOI
Cheminformatics analysis and learning in a data pipelining environment
TL;DR: It is demonstrated that SciTegic's methodology for molecular fingerprints, molecular similarity, molecular clustering, maximal common subgraph search and Bayesian learning are well suited to a wide variety of tasks.
Journal ArticleDOI
Immune responses in cancer
TL;DR: It is likely that the best strategy to combat cancer may require multiple immunotherapeutic strategies in order to demonstrate benefit in different patient populations, and the best results are obtained with vaccines in combination with a variety of immunotherapy combinations.
Journal ArticleDOI
CDK inhibitors in clinical development for the treatment of cancer
TL;DR: The preclinical and clinical results obtained so far with flavopiridol, 7-hydroxystaurosporine, roscovitine and roscavitine are summarised and the potential for monotherapy and applications in combination with existing drugs are discussed.
Journal Article
Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
TL;DR: It is demonstrated that flavopiridol is associated with a dose-dependent increase in E2F1 protein levels, a corresponding reduction in Mcl-1, and apoptosis in H1299 lung carcinoma cells, suggesting that apoptosis induced by flavopirsol is dependent on the enhancement of E 2F1 levels and the repression of M cl-1.